Research America is located in Arlington, VA. The organization was established in 1989. According to its NTEE Classification (V99) the organization is classified as: Social Science N.E.C., under the broad grouping of Social Science and related organizations. As of 12/2023, Research America employed 36 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Research America is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Research America generated $7.0m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 9.0% each year. All expenses for the organization totaled $7.9m during the year ending 12/2023. While expenses have increased by 10.0% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ADVOCATES FOR SCIENCE, DISCOVERY AND INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ADVOCATING FOR SCIENCE, DISCOVERY, AND INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL:FOLLOWING OUR STRATEGIC FRAMEWORK, WE WORKED TO BOOST FUNDING IN FISCAL YEAR 2023 FOR FEDERAL RESEARCH AGENCIES, INCLUDING A $2.5 BILLION INCREASE FOR THE NATIONAL INSTITUTES OF HEALTH (NIH) AND A $1 BILLION INCREASE FOR THE NATIONAL SCIENCE FOUNDATION (NSF). OUR EFFORTS HELPED BREAK THE LOGJAM PREVENTING SENATE CONFIRMATION NEW OF THE NIH DIRECTOR; FOSTERED INTERNATIONAL RESEARCH PARTNERSHIPS AND PANDEMIC PREPAREDNESS FUNDING IN SUPPORT OF U.S. AND GLOBAL HEALTH, SECURITY, AND PROSPERITY. ACTIONS TO ACCOMPLISH OUR GOALS INCLUDES 42 CONGRESSIONAL MEETINGS, 22 MEETINGS WITH EXECUTIVE BRANCH OFFICIALS AND KEY FEDERAL STAKEHOLDERS: 153 UNIQUE WRITTEN COMMUNICATIONS AND SIGN-ON LETTERS TO POLICYMAKERS, AND 43 ACTION ALERTS. TO PROVIDE OUR MEMBERS WITH ADVOCACY TOOLS, WE DEVELOPED 40 BRIEFING PAPERS AND ENGAGEMENT RESOURCES, INCLUDING UPDATED FACT SHEETS ON DISEASE THREATS AND EMERGING HEALTH TECHNOLOGIES; AN INFOGRAPHIC AND ON THE R&D PIPELINE; BAYH-DOLE ACT RESOURCES, AND NEW ADVOCACY AND COMMUNICATIONS TOOLS FOR ENGAGING POLICYMAKERS AND THE PUBLIC. WE HOSTED 53 ALLIANCE DISCUSSIONS ON AN ARRAY TO TOPICS TO HELP INFORM MEMBERS AND STAKEHOLDERS. WE ISSUED A WEEKLY NEWSLETTER FROM CEO MARY WOOLLEY PROVIDING TIMELY INFORMATION ON FEDERAL R&D POLICY AND FUNDING DEVELOPMENTS, AS WELL AS ADVOCACY OPPORTUNITIES AND TOOLS.
SCIENCE OUTREACH AND CIVIC ENGAGEMENT:THE CIVIC ENGAGEMENT MICROGRANT PROGRAM IN 2023 WAS OUR 6TH YEAR EMPOWERING EARLY-CAREER SCIENCE CIVIC ENGAGEMENT THROUGH COMPETITIVE MICROGRANTS. THE PROGRAM WAS HIGHLY COMPETITIVE WITH 20 GRANTS FUNDED FROM ACROSS THE COUNTRY. WE RELEASED A REPORT, "VISUALIZING THE LANDSCAPE OF TRAINING INITIATIVES FOR SCIENTISTS IN PUBLIC ENGAGEMENT IN THE UNITED STATES," WHICH OFFERS A DETAILED OVERVIEW OF THE SCOPE OF TRAINING INITIATIVES FOR SCIENTISTS IN PUBLIC ENGAGEMENT. NOTABLY, THE REPORT INCLUDES AN INTERACTIVE DASHBOARD THAT PROVIDES A DYNAMIC WINDOW INTO THESE IMPORTANT AND DEVELOPING PROGRAMS ACROSS THE U.S. RESEARCH!AMERICA CONTINUES TO COORDINATE AND SUPPORT THE SCIENCE AND TECHNOLOGY ACTION COMMITTEE, AN INITIATIVE THAT HAS BROUGHT A DIVERSITY OF THOUGHT LEADERS TOGETHER TO MAKE THE CASE FOR A FAR BOLDER APPROACH TO BOLSTERING THE NATION'S R&D CAPACITY, INCLUDING SIGNIFICANTLY INCREASING THE PERCENTAGE OF THE GDP DEVOTED TO SCIENCE INVESTMENT.
GLOBAL HEALTH R&D ADVOCACY: IN 2023, RESEARCH!AMERICA EXPANDED ITS GLOBAL HEALTH R&D ADVOCACY PROGRAM, COMPLETING THE SECOND YEAR OF A MULTI-YEAR GRANT PROJECT FUNDED BY THE BILL & MELINDA GATES FOUNDATION. THE GOAL OF THE PROJECT IS TO INCREASE UNITED STATES GOVERNMENT NON-OFFICIAL DEVELOPMENT ASSISTANCE (ODA) FUNDING FOR GLOBAL HEALTH RESEARCH & DEVELOPMENT, WITH PARTICULAR EMPHASIS ON ADVANCING INNOVATIVE CROSS-SECTOR PARTNERSHIPS AND OTHER EFFICIENCY-CREATING R&D STRATEGIES, INCLUDING PLATFORM TECHNOLOGIES AND GLOBAL CLINICAL TRIAL NETWORKS. SINCE THE NIH IS THE LARGEST FUNDER OF GLOBAL INFECTIOUS DISEASE RESEARCH IN THE WORLD AND GIVEN THAT WE ARE ALSO STRONG ADVOCATES FOR OTHER AGENCIES IN THE GLOBAL HEALTH ARENA (E.G., CDC) OUR WORK UNDER THE GRANT IS WELL INTEGRATED INTO OUR OVERALL ADVOCACY AND POLICY AGENDA. REPRESENTATIVE EFFORTS TO DATE INCLUDE PLAYING A VOCAL ROLE IN SECURING FEDERAL FUNDING FOR PANDEMIC PREPAREDNESS R&D, ASSURING THAT THE ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) CONSIDERS OR REFERS PROJECTS APPROPRIATELY IN THE GLOBAL HEALTH R&D ARENA; ADVANCING SURVEILLANCE AND RESEARCH IN THE AREA OF NEGLECTED TROPICAL DISEASES; AND FILLING GAPS IN FUNDING FOR EMERGING INFECTIOUS DISEASES AT THE BIOMEDICAL ADVANCED RESEARCH & DEVELOPMENT AUTHORITY (BARDA). OUR PRIVATE SECTOR WORK IS FOCUSED ON EXPLORING POTENTIAL NEW INCENTIVES TO ATTRACT PRIVATE SECTOR INVESTMENT TO GLOBAL HEALTH R&D EFFORTS, AND FOSTERING CONNECTIONS BETWEEN RESEARCH ORGANIZATIONS IN THE GLOBAL SOUTH AND POTENTIAL PRIVATE SECTOR PARTNERS IN THE U.S.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Mary Woolley President & Chief Executive Officer | OfficerTrustee | 50 | $617,813 |
Sudip Parikh PHD Chair (as Of 04/2023) | OfficerTrustee | 3 | $0 |
Susan Dentzer Chair (until 04/2023) | OfficerTrustee | 3 | $0 |
Hon Michael Castle Chair Emeritus (until 04/2023) | OfficerTrustee | 3 | $0 |
Georges Benjamin MD Vice Chair | OfficerTrustee | 2 | $0 |
Amy Comstock Rick JD Treasurer | OfficerTrustee | 2 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Subject Matter - Home Front Advocacy/communications | 12/30/23 | $667,724 |
Keefe Signiser Partners Government Relations | 12/30/23 | $240,000 |
Perkins Coie Llp Policy/strategy | 12/30/23 | $180,000 |
Kountoupes Denham Carr & Reid Government Relations | 12/30/23 | $165,019 |
Fgs Global Focus Group And Opinion Research | 12/30/23 | $125,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $4,421,376 |
Noncash contributions included in lines 1a–1f | $28,499 |
Total Revenue from Contributions, Gifts, Grants & Similar | $4,421,376 |
Total Program Service Revenue | $2,373,400 |
Investment income | $199,898 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $20,671 |
Net Gain/Loss on Asset Sales | -$18,181 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $6,997,174 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $273,796 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,021,022 |
Compensation of current officers, directors, key employees. | $343,278 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $2,855,159 |
Pension plan accruals and contributions | $175,860 |
Other employee benefits | $240,550 |
Payroll taxes | $240,616 |
Fees for services: Management | $0 |
Fees for services: Legal | $9,275 |
Fees for services: Accounting | $75,797 |
Fees for services: Lobbying | $314,609 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $88,520 |
Fees for services: Other | $1,397,122 |
Advertising and promotion | $198,754 |
Office expenses | $34,327 |
Information technology | $117,981 |
Royalties | $0 |
Occupancy | $230,081 |
Travel | $100,296 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $177,368 |
Interest | $171 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $71,765 |
Insurance | $18,446 |
All other expenses | $16,008 |
Total functional expenses | $7,913,359 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $605,029 |
Savings and temporary cash investments | $1,489,562 |
Pledges and grants receivable | $1,883,107 |
Accounts receivable, net | $5,953 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $20,888 |
Net Land, buildings, and equipment | $240,750 |
Investments—publicly traded securities | $6,124,623 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $1,576,255 |
Total assets | $11,946,167 |
Accounts payable and accrued expenses | $610,583 |
Grants payable | $0 |
Deferred revenue | $225,579 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,924,900 |
Total liabilities | $2,761,062 |
Net assets without donor restrictions | $1,442,725 |
Net assets with donor restrictions | $7,742,380 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $11,946,167 |